Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole loading-dose comparison for invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure
ChiCTR1900024124Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of voriconazole in Acute Invasive Aspergillosis (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Antifungal effect and Voriconazole plasma concentration. Started Jun 2019; status: recruiting.
02
Drugs
voriconazole
03
Conditions
Acute Invasive Aspergillosis
Beyond the preview
Go deeper on ChiCTR1900024124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024124.